Top

Published in:

01-05-2021 | Systemic Lupus Erythematosus

The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock

Authors: Maya Guglin, Carson Smith, Roopa Rao

Published in: Heart Failure Reviews | Issue 3/2021

Abstract

Lupus myocarditis is a serious, potentially deadly disease. When it presents as an acute or fulminant myocarditis in a patient without an established diagnosis of lupus, lupus as an etiology of the condition is not commonly suspected. Meanwhile, it has a distinct treatment which may be lifesaving. Review of the literature can shed more light as current management is mostly based on clinical experience and case reports rather than randomized control trials. In this review we are discussing this diagnostic entity, focusing on cardiogenic shock as a manifestation of lupus myocarditis, and discussing management including aggressive immunosuppression, mechanical circulatory support, and cardiac transplantation.

Ansari A, Larson PH (1985) Heart disease in systemic lupus erythematosus: diagnosis and management. Tex Heart Inst J 12(1):9–21PubMedPubMedCentral

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL et al (2019) 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 71(9):1400–1412PubMedPubMedCentral

Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, van Overeem Hansen G, Skaarup B et al (1998) A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 17(6):478–484PubMed

Apte M, McGwin Jr. G, Vila LM, Kaslow RA, Alarcon GS, Reveille JD (2008) Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected]. Rheumatology (Oxford) 47(3):362–367

Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 58(2):243–264PubMed

Doherty NE 3rd, Feldman G, Maurer G, Siegel RJ (1988) Echocardiographic findings in systemic lupus erythematosus. Am J Cardiol 61(13):1144PubMed

Leung WH, Wong KL, Lau CP, Wong CK, Cheng CH (1990) Cardiac abnormalities in systemic lupus erythematosus: a prospective M-mode, cross-sectional and Doppler echocardiographic study. Int J Cardiol 27(3):367–375PubMed

Chang JC, Xiao R, Mercer-Rosa L, Knight AM, Weiss PF (2018) Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease. Lupus 27(13):2146–2154PubMedPubMedCentral

Du Toit R, Herbst PG, van Rensburg A, du Plessis LM, Reuter H, Doubell AF (2017) Clinical features and outcome of lupus myocarditis in the Western Cape. South Africa Lupus 26(1):38–47PubMed

10.

Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hie M, Hervier B, Costedoat-Chalumeau N, Mazodier K, Ebbo M, Cluzel P et al (2017) Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol 44(1):24–32PubMed

11.

Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB (2018) Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus 27(8):1296–1302PubMed

12.

Law WG, Thong BY, Lian TY, Kong KO, Chng HH (2005) Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus 14(10):827–831PubMed

13.

Jia E, Geng H, Liu Q, Xiao Y, Zhang Y, Xie J, Zhang L, Qiu X, Zhong L, Xiao M et al (2019) Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study. Ir J Med Sci 188(3):801–806PubMed

14.

Zhang L, Zhu YL, Li MT, Gao N, You X, Wu QJ, Su JM, Shen M, Zhao LD, Liu JJ et al (2015) Lupus myocarditis: a case-control study from China. Chin Med J (Engl) 128(19):2588–2594

15.

Logar D, Kveder T, Rozman B, Dobovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49(8):627–629PubMedPubMedCentral

16.

Zawadowski GM, Klarich KW, Moder KG, Edwards WD, Cooper LT Jr (2012) A contemporary case series of lupus myocarditis. Lupus 21(13):1378–1384PubMed

17.

Perel-Winkler A, Bokhari S, Perez-Recio T, Zartoshti A, Askanase A, Geraldino-Pardilla L (2018) Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography. Lupus Sci Med 5(1):e000265PubMedPubMedCentral

18.

Borenstein DG, Fye WB, Arnett FC, Stevens MB (1978) The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med 89(5 Pt 1):619–624PubMed

19.

Ishimori ML, Agarwal M, Beigel R, Ng RK, Firooz N, Weisman MH, Siegel RJ (2014) Systemic lupus erythematosus cardiomyopathy—a case series demonstrating a reversible form of left ventricular dysfunction. Echocardiography 31(5):563–568PubMed

20.

Gartshteyn Y, Tamargo M, Fleischer S, Kapoor T, Li J, Askanase A, Winchester R, Geraldino-Pardilla L (2020) Endomyocardial biopsies in the diagnosis of myocardial involvement in systemic lupus erythematosus. Lupus 29(2):199–204PubMedPubMedCentral

21.

Chen J, Tang Y, Zhu M, Xu A (2016) Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis. Clin Rheumatol 35(10):2437–2448PubMed

22.

Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Bounas A, Tektonidou M, Lliossis SC, Daoussis D, Plastiras S, Karabela G, Stavropoulos E et al (2018) Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus. Lupus 27(4):564–571PubMed

23.

Saremi F, Ashikyan O, Saggar R, Vu J, Nunez ME (2007) Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis. Int J Cardiovasc Imaging 23(3):347–352PubMed

24.

Singh JA, Woodard PK, Dávila-Román VG, Waggoner AD, Gutierrez FR, Zheng J, Eisen SA (2005) Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus 14(2):137–144PubMed

25.

Fairfax MJ, Osborn TG, Williams GA, Tsai CC, Moore TL (1988) Endomyocardial biopsy in patients with systemic lupus erythematosus. J Rheumatol 15(4):593–596PubMed

26.

Jain D, Halushka MK (2009) Cardiac pathology of systemic lupus erythematosus. J Clin Pathol 62(7):584–592PubMed

27.

Cervera A, Espinosa G, Font J, Ingelmo M (2001) Cardiac toxicity secondary to long term treatment with chloroquine. Ann Rheum Dis 60(3):301PubMedPubMedCentral

28.

Gottenberg JE, Roux S, Assayag P, Clerc D, Mariette X (2004) Specific cardiomyopathy in lupus patients: report of three cases. Joint Bone Spine 71(1):66–69PubMed

29.

Naarendorp M, Kerr LD, Khan AS, Ornstein MH (1999) Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol 26(10):2257–2260PubMed

30.

Wang CR, Tsai YS, Li WT (2018) Lupus myocarditis receiving the rituximab therapy-a monocentric retrospective study. Clin Rheumatol 37(6):1701–1707PubMed

31.

de Groot KA, Tsang ASM, Niewerth D, Cloos J, Blank JL, Niessen HW, Zweegman S, Voskuyl AE, Jansen G, van der Heijden JW (2015) Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis. Lupus Sci Med 2(1):e000121PubMedPubMedCentral

32.

Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18(3):238–240PubMed

33.

Micheloud D, Calderon M, Caparrros M, D’Cruz DP (2007) Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients. Ann Rheum Dis 66(7):986–987PubMedPubMedCentral

34.

Suri V, Varma S, Joshi K, Malhotra P, Kumari S, Jain S (2010) Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy. Rheumatol Int 30(11):1503–1505PubMed

35.

Battisha A, Sawalha K, Altibi AM, Madoukh B, Al-Akchar M, Patel B (2020) Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes. Heart Fail Rev

36.

Disla E, Rhim HR, Reddy A, Ramaprasad S, Taranta A (1993) Reversible cardiogenic shock in a patient with lupus myocarditis. J Rheumatol 20(12):2174PubMed

37.

Leung MC, Harper RW, Boxall J (2002) Extracorporeal membrane oxygenation in fulminant myocarditis complicating systemic lupus erythematosus. Med J Aust 176(8):374–375PubMed

38.

Griveas I, Sourgounis A, Visvardis G, Zarifis I, Kyriklidou P, Sakellariou G (2004) Immunoadsorption in lupus myocarditis. Ther Apher Dial 8(4):281–285PubMed

39.

Anis A, Saric M, Haider B, Cohen ZI, Ather A, Klapholz MJC (2006) Lupus myocarditis treated with intravenous immunoglobulin under hemodynamic monitoring. 130(4):292S

40.

van der Laan-Baalbergen NE, Mollema SA, Kritikos H, Schoe A, Huizinga TW, Bax JJ, Boumpas DT, van Laar JM (2009) Heart failure as presenting manifestation of cardiac involvement in systemic lupus erythematosus. Neth J Med 67(9):295–301PubMed

41.

Gurjar M, Singhal S, Poddar B, Baronia AK, Azim A (2010) Acute cardiogenic shock in a girl with systemic lupus erythematosus. Indian J Crit Care Med 14(4):209–211PubMedPubMedCentral

42.

Penataro JS, De Mingo A, Del Rio A, Martinez JA, Heras M, Regueiro A (2012) Myopericarditis and severe myocardial dysfunction as the initial manifestation of systemic lupus erythematosus. Eur Heart J Acute Cardiovasc Care 1(3):253–255PubMedPubMedCentral

43.

Baquero G, Banchs JE, Naccarelli GV, Gonzalez M, Wolbrette DL (2012) Cardiogenic shock as the initial presentation of systemic lupus erythematosus: a case report and review of the literature. Congest Heart Fail 18(6):337–341PubMed

44.

Barnado A, Kamen DL (2014) Myocarditis successfully treated with intravenous immunoglobulin in a patient with systemic lupus erythematous and myositis. Am J Med Sci 347(3):256–257PubMed

45.

Malhotra G, Chua S, Kodumuri V, Sivaraman S, Ramdass P (2016) Rare presentation of lupus myocarditis with acute heart failure—a case report. Am J Ther 23(6):e1952–e1955PubMed

46.

Castellanos-Moreira R, Rodriguez-Garcia S, Lopez-Sobrino T, Capdevila A, Prieto-Gonzalez S, Espinosa G (2017) Successful extracorporeal membrane oxygenation in a patient with fulminant lupus myocarditis. Rev Esp Cardiol (Engl Ed) 70(11):1013–1014

47.

Bouiller K, Naudion P, Humbert S, Gil H, Meaux-Ruault N, Cravat M, Revel L, Molimard C, Seronde MF, Magy-Bertrand N (2018) Cardiac shock revealing systemic lupus erythematosus. Circ Heart Fail 11(7):e005159PubMed

48.

Rathi A, Das M, Singhal R, Ramasubbu K (2018) Lupus Myocarditis Presenting as Acute Cardiogenic Shock: A Rare Presentation. In: B47 CRITICAL CARE CASE REPORTS: CARDIOVASCULAR DISEASES AND ECHOCARDIOGRAPHY. American Thoracic Society A3458-A3458

49.

Elsayed A, Dawood MA, Abada MH, Beltagy A (2018) A case of lupus myocarditis presenting as acute cardiogenic shock. In: Eur J Heart Fail: WILEY 111 RIVER ST, HOBOKEN 07030–5774, NJ USA; 2018: 369–369

50.

Hawkins AM, Jesuthasan LSB, Vardesh DL (2018) Case of severe acute lupus myocarditis and multiple-organ failure. BMJ Case Rep

51.

Rebelato JB, Silveira C, Valadao TFC, Reis FM, Bazan R, Bazan SGZ (2018) Myocarditis with cardiogenic shock as the first manifestation of systemic lupus erythematosus. Arq Bras Cardiol 111(6):864–866PubMedPubMedCentral

52.

Tariq S, Garg A, Gass A, Aronow WS (2018) Myocarditis due to systemic lupus erythematosus associated with cardiogenic shock. Arch Med Sci 14(2):460–462PubMed

53.

Schultz M, Wimberly K, Guglin M (2019) Systemic lupus and catastrophic antiphospholipid syndrome manifesting as cardiogenic shock. Lupus 28(11):1350–1353PubMed

54.

Liu L, Dong Y, Gao H, Yao D, Zhang R, Zheng T, Jin Y, Lv B, Tian Y (2020) Cardiogenic shock as the initial manifestation of systemic lupus erythematosus. ESC heart failure

55.

Reich HJ, Awad M, Ruzza A, De Robertis MA, Ramzy D, Nissen N, Colquhoun S, Esmailian F, Trento A, Kobashigawa J et al (2015) Combined heart and liver transplantation: the cedars-sinai experience. Transplant Proc 47(9):2722–2726PubMed

56.

Stern LK, Selby VN, Kolaitis NA, Boin F, Aras M, Klein L, De Marco T (2020) Heart-lung transplantation: a viable option for connective tissue diseases. Clin Transplant 34(2):e13776PubMed

57.

Tweezer-Zaks N, Zandman-Goddard G, Lidar M, Har-Zahav Y, Livneh A, Langevitz P (2007) A long-term follow-up after cardiac transplantation in a lupus patient: case report and review of the literature. Ann N Y Acad Sci 1110:539–543PubMed

58.

Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR (1990) Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17(10):1292–1298PubMed

59.

DiSesa VJ, Sloss LJ, Cohn LH (1990) Heart transplantation for intractable prosthetic valve endocarditis. J Heart Transplant 9(2):142–143PubMed

60.

Levy RD, Guerraty AJ, Yacoub MH, Loertscher R (1993) Prolonged survival after heart-lung transplantation in systemic lupus erythematosus. Chest 104(6):1903–1905PubMed

61.

Yeatman M, McNeil K, Smith JA, Stewart S, Sharples LD, Higenbottam T, Wells FC, Wallwork J (1996) Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital. J Heart Lung Transplant 15(2):144–149PubMed

Title: The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock
Authors: Maya Guglin
Carson Smith
Roopa Rao
Publication date: 01-05-2021
Publisher: Springer US
Keywords: Systemic Lupus Erythematosus
Myocarditis
Cardiogenic Shock
Cardiogenic Shock
Published in: Heart Failure Reviews / Issue 3/2021
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-020-10054-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2021

Cardiogenic shock and acute kidney injury: the rule rather than the exception

Machine learning and statistical methods for predicting mortality in heart failure

Serum potassium and heart failure: association, causation, and clinical implications

The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review

Psychological stress in heart failure: a potentially actionable disease modifier

Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors